Boehringer Ingelheim Head External Innovation - Vaccine R&D in DULUTH, Georgia
Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and communities.
To expand and improve our global external network of research collaborators to ensure that we have access to the foremost technologies and expertise in vaccinology, genetics, bioinformatics, proteomics, immunology, vaccine delivery technologies, vectors and expression systems, and that these are incorporated into projects when strategically and commercially appropriate. To ensure that BI Vaccine R&D has "first right of refusal" on new technologies, and that we are the commercialization partner of choice for AH vaccine startups. To ensure we are best positioned in the industry to address emerging diseases.
As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees
Duties & Responsibilities:
Develop a global external innovation strategy aligned with Vaccine R&D strategy and leadership, SBUs and Industrial operations and budget. Build gap analysis and road map to achieve strategy.
Oversee all external innovation contracts and budget in association with finance, legal and R&D leadership
Have a clear scientific understanding of all priority projects across all species/ functions, ensure current knowledge and evaluation of external technologies and partners, and make connections to benefit projects.
Ensure all external collaborations are in BI's best interests in terms of ROI, IP, reputation, in line with BD, IP and legal
Align with businesses in EU, US, China on key global emerging disease threats and ensure we have collaborations in place with leading institutes to be an industry leader in addressing emerging diseases
Science-based PhD from an accredited institution required
Requires a deep understanding of vaccinology, current scientific trends and their applicability, and a broad network of internal and external industry and academic collaborations. An understanding and experience of budget management. Ability to work collaboratively with conflicting priorities, juggle multiple projects and multiple stakeholders.
At least ten (10) years’ experience of vaccine R&D post PhD, including a deep understanding of infectious disease, technologies of genetics, molecular biology, protein expression, vaccine delivery. Some knowledge of bioinformatics, diagnostics and bioprocess science and advantage.
An experienced scientist with a strong academic network who can represent the company in high-level scientific and basic commercial discussions.
An ability to quickly synthesize complex information and see commercial possibilities. An ability to see applications of technologies across disciplines.
Ability to work collaboratively, to engage strong scientists and also hold research partners accountable.
Proven ability to communicate cross-culturally.
Must be legally authorized to work in the United States without restriction
Must be willing to take a drug test and post-offer physical (if required)
Must be 18 years of age or older
Boehringer Ingelheim is one of the world’s top 20 pharmaceutical companies and operates globally with approximately 50,000 employees. Since our founding in 1885, the company has remained family-owned and today we are committed to creating value through innovation in three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. Since we are privately held, we have the ability to take an innovative, long-term view. Our focus is on scientific discoveries and the introduction of truly novel medicines that improve lives and provide valuable services and support to patients and their families. Employees are challenged to take initiative and achieve outstanding results. Ultimately, our culture and drive allows us to maintain one of the highest levels of excellence in our industry. We are also deeply committed to our communities and our employees create and engage in programs that strengthen the neighbourhoods where we live and work. Boehringer Ingelheim, including Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA, Boehringer Ingelheim Animal Health USA, Inc., Merial Barceloneta, LLC and Boehringer Ingelheim Fremont, Inc. is an equal opportunity and affirmative action employer committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender identity or expression; affectional or sexual orientation; disability; veteran or military status, including protected veteran status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.
Boehringer Ingelheim is firmly committed to ensuring a safe, healthy, productive and efficient work environment for our employees, partners and customers. As part of that commitment, Boehringer Ingelheim conducts pre-employment verifications and drug screenings.
Organization: US-Merial, Inc.
Title: Head External Innovation - Vaccine R&D
Requisition ID: 189809